Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Jul 21, 2026
Episode
370
Soundcloud
Share
How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology.
Guest
Vincent Lam
MD
Associate Professor of Oncology, Johns Hopkins University School of Medicine
Director, Thoracic Oncology Clinical Research Program
Sidney Kimmel Comprehensive Cancer Center
Carmen Mecca
PhD
Postdoctoral Fellow, Chiarle Lab
Department of Pathology
Boston Children’s Hospital
